Wednesday, July 8, 2026

Drug profile · INN

piperazine citrate

piperazine citrate (PIPERAZINE CITRATE) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — piperazine citrate
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

piperazine citrate (PIPERAZINE CITRATE) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN piperazine citrate
Brand PIPERAZINE CITRATE
Mechanism Nematode GABA-A receptor positive modulator
Target Nematode GABA-A receptor
Route ORAL
Formulation SYRUP

Mechanism of action

Nematode GABA-A receptor positive modulator

Primary target: Nematode GABA-A receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Prilocaine (Hyperbaric 2%) Approved · United Therapeutics Europe · Cervical Incompetence in Pregnancy as Antepartum Condition

Related & competitor drugs

  1. diethylcarbamazine citrate Nematode GABA-A receptor positive modulator

Frequently asked questions

What is piperazine citrate?

piperazine citrate (PIPERAZINE CITRATE) is a nematode gaba-a receptor positive modulator. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for piperazine citrate?

PIPERAZINE CITRATE is a marketed brand name for piperazine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of piperazine citrate?

piperazine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.